The global point of care/rapid diagnostics market is to increase from US$ 31,021 million in 2020 to US$ 53,226 million by 2025 with a compound annual growth rate (CAGR) of 11.4% for the period 2020-2025. Some of the prominent players in the point of care/rapid diagnostics market are Abbott Laboratories, Accubiotech Co., Ltd., Becton, Dickinson And Company, Chembio Diagnostics, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc , F. Hoffmann-La Roche Ag, Instrumentation Laboratory Company, Johnson & Johnson Services Inc., Nova Biomedical Corporation, Polymer Technology Systems, Inc., Quidel Corporation, Sekisui Diagnostics, Llc, Siemens Healthineers Ag, Trinity Biotech Plc. The research report on the global point of care/rapid diagnostics market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the point of care/rapid diagnostics market. The global economy is highly affected by the COVID-19. Various sectors in the economy are much affected by this pandemic. It is anticipated that the global economy will decline because of the loss of trillions of dollars. The growing extension and imposition of lockdown in various countries directly affect the economy all over the world. The report consists of a chapter that provides a detailed study of the impact of COVID-19 on the point of care/rapid diagnostics market. The data in this report is targeted for business and industry practitioners and specifically intended to assist in the explanation, direction, and to understand the potential of the point of care/rapid diagnostics markets. The study focuses on providing readers with an understanding of developments in the industry, market segments, market forecasts, leading players, and market drivers and inhibitors.

Goals and objectives of the study

Understanding the opportunities and advancements of point of care/rapid diagnostics is determining the market highlights, along with the foremost regions and countries involved in the growth of the market.

To study the diverse segments of the point of care/rapid diagnostics market and the dynamics of point of care/rapid diagnostics in the market.

To categorize segments of point of care/rapid diagnostics with escalating growing potential and to value the futuristic market of the segments.

To analyze the major trends related to different segments that help in figuring and persuading the point of care/rapid diagnostics market.

To check region-specific growth and development in the point of care/rapid diagnostics market.

To understand the foremost stakeholders of the point of care/rapid diagnostics market and the value of the competitive landscape of the leaders of the point of care/rapid diagnostics market.

To study the key plans, initiatives, and strategies for the development of the point of care/rapid diagnostics market.

Chapter 2, Market Overview provides an overview of the point of care/rapid diagnostics market. The chapter includes macro-economic factors, market determinants (includes market drivers, restraints, opportunities, and challenges), value chain analysis, technology/product roadmap, Porter 5 force model analysis, market growth opportunity analysis.

Chapter 3, Segment Analysis of the study deals with the different sub-segments of the market to calculate reliable market forecasts. The chapter provides an in-depth analysis of the market segments of the point of care/rapid diagnostics market, year-on-year growth projections that enable readers to identify potential market growth areas.

Market Segmentation

Based on product, the global point of care/rapid diagnostics market is segmenting into cardiometabolic monitoring products, cholesterol testing products, coagulation monitoring products, drugs-of-abuse testing products, fecal occult testing products, glucose monitoring products, hematology testing products, infectious disease testing products, other poc products, pregnancy & fertility testing products, tumor/cancer marker testing products, urinalysis testing product.

Based on platform, the point of care/rapid diagnostics market is segmenting into dipsticks, immunoassays, lateral flow assays,microfluidics, molecular diagnostics .

Based on mode of purchase, the point of care/rapid diagnostics market is segmenting into otc testing products, prescription-based testing products .

Based on end users, the point of care/rapid diagnostics market is segmenting into home care settings, hospitals & critical care centers, outpatient & ambulatory care facilities, other .

Chapter 4, Regional Analysis includes an in-depth analysis of the point of care/rapid diagnostics market by regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report also includes a comprehensive analysis of the market in key countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers of the point of care/rapid diagnostics market report to explore the potential of the market in different geographies. For each year's growth projections and a global share of value, this section is a vital part of the report.

Chapter 5, Competitive Analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.

Chapter 6, Company Profile of the report also covers key industry players working on the point of care/rapid diagnostics market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.

The study offers an exhaustive summary and estimate of the global point of care/rapid diagnostics market. It includes in-depth qualitative and quantitative analyses in the report that aligned with the goals and objectives of our customers. Projections have been confirmed by comprehensive primary and secondary analysis. The study will encourage clients to invest in the point of care/rapid diagnostics market based on the current business situation, trends, and potential developments in the segments. Understanding the requirement of the client, the report delivers specialist insights into the global point of care/rapid diagnostics market, its products, and market patterns.